These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16977258)

  • 1. Accuracy of continuous subcutaneous glucose monitoring with the GlucoDay in type 1 diabetic patients treated by subcutaneous insulin infusion during exercise of low versus high intensity.
    Fayolle C; Brun JF; Bringer J; Mercier J; Renard E
    Diabetes Metab; 2006 Sep; 32(4):313-20. PubMed ID: 16977258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion.
    Kapitza C; Hövelmann U; Nosek L; Kurth HJ; Essenpreis M; Heinemann L
    J Diabetes Sci Technol; 2010 Jan; 4(1):123-31. PubMed ID: 20167176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans.
    Rossetti P; Porcellati F; Fanelli CG; Bolli GB
    Diabetes Technol Ther; 2006 Jun; 8(3):326-37. PubMed ID: 16800754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial.
    Moser O; Eckstein ML; Mueller A; Birnbaumer P; Aberer F; Koehler G; Sourij C; Kojzar H; Holler P; Simi H; Pferschy P; Dietz P; Bracken RM; Hofmann P; Sourij H
    Diabet Med; 2019 May; 36(5):606-611. PubMed ID: 30677187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous glucose monitoring with GlucoDay: comparison of the results to those obtained with the endocrine artificial pancreas.
    Dimitriadis G; Boutati E; Raptis AE; Hatziagelaki E; Mitrou P; Lambadiari V; Tountas N; Economopoulos T; Raptis SA
    Hormones (Athens); 2010; 9(2):145-50. PubMed ID: 20687398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the continuous glucose monitoring system.
    Bode BW
    Diabetes Technol Ther; 2000; 2 Suppl 1():S35-41. PubMed ID: 11469630
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
    Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
    Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.
    Guerci B; Floriot M; Böhme P; Durain D; Benichou M; Jellimann S; Drouin P
    Diabetes Care; 2003 Mar; 26(3):582-9. PubMed ID: 12610005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients.
    Wentholt IM; Vollebregt MA; Hart AA; Hoekstra JB; DeVries JH
    Diabetes Care; 2005 Dec; 28(12):2871-6. PubMed ID: 16306547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes.
    Li A; Riddell MC; Potashner D; Brown RE; Aronson R
    Diabetes Technol Ther; 2019 May; 21(5):286-294. PubMed ID: 31017497
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time?
    Mazze RS; Strock E; Borgman S; Wesley D; Stout P; Racchini J
    Diabetes Technol Ther; 2009 Jan; 11(1):11-8. PubMed ID: 19132850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
    Jungheim K; Wientjes KJ; Heinemann L; Lodwig V; Koschinsky T; Schoonen AJ;
    Diabetes Care; 2001 Sep; 24(9):1696-7. PubMed ID: 11522729
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study.
    Hoss U; Jeddi I; Schulz M; Budiman E; Bhogal C; McGarraugh G
    Diabetes Technol Ther; 2010 Aug; 12(8):591-7. PubMed ID: 20615099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance.
    Kubiak T; Wörle B; Kuhr B; Nied I; Gläsner G; Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2006 Oct; 8(5):570-5. PubMed ID: 17037971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis.
    Maran A; Crepaldi C; Tiengo A; Grassi G; Vitali E; Pagano G; Bistoni S; Calabrese G; Santeusanio F; Leonetti F; Ribaudo M; Di Mario U; Annuzzi G; Genovese S; Riccardi G; Previti M; Cucinotta D; Giorgino F; Bellomo A; Giorgino R; Poscia A; Varalli M
    Diabetes Care; 2002 Feb; 25(2):347-52. PubMed ID: 11815508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.
    Mastrototaro J; Shin J; Marcus A; Sulur G;
    Diabetes Technol Ther; 2008 Oct; 10(5):385-90. PubMed ID: 18715215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
    Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
    Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device.
    Manuel-y-Keenoy B; Vertommen J; Abrams P; Van Gaal L; De Leeuw I; Messeri D; Poscia A
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S24-31. PubMed ID: 15551295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.